Modern risk scores in cardiology;Moderne risiko-scores in der kardiologie

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 40, 2009, Pages 2001-2005

  Gohlke, H ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Cardiovascular prevention; Number needed to treat; Primary prevention; Risk; Risk stratification

Indexed keywords

ACUTE CORONARY SYNDROME; ALGORITHM; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY SURGERY; GROUPS BY AGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMOBILIZATION; LIFESTYLE MODIFICATION; OBESITY; PRIMARY PREVENTION; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SURGICAL RISK; CARDIOVASCULAR DISEASE;

CARDIOVASCULAR DISEASES; HUMANS; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 70349760031     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1237546     Document Type: Review

References (19)

1. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation 2005; 112: 224-231
2. Assmann G, Cullen P, Schulte H. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation 2002; 105: 310-315
3. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003
4. De Araujo Gonvalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005; 26: 865-872
5. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135: 180-187
6. Gohlke H, Albus C, Bönner G et al. Pocket-Leitlinien: Risikoadjustierte Prävention von Herz und Kreislauferkrankungen. www.dgk.org/leitlinien 2008
7. Gotto AM for the AFCAPS/TexCAPS Research Group. Primary prevention of acute Coronary events with Lovastatin in men and women with average Cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615-1622
8. Greving JP, Buskens E, Koffijberg H, Algra A. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Circulation 2008; 117: 2875-2883
9. Gummert JF, Funkat A, Osswald B, Beckmann A, Schiller W, Krian A, Beyersdorf F, Haverich A, Cremer J. Euro-SCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 2009 March 5. [Epub ahead of print]
10. Heidrich J, Wellmann J, Hense H-W et al. Klassische Risikofaktoren für Herzinfarkt und Gesamtsterblichkeit in der Bevölkerung. 13-Jahres- Follow-up der MONICA Augsburg-Kohortenstudie. Z Kardiol 2003; 92: 445-454
11. Hense HW, Schulte H, Löwel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany. Results from the MONICA Augsburg cohort and the PROCAM cohorts. Eur Heart J 2003; 24: 937-945
12. Keil U, Fitzgerald AP, Gohlke H, Wellmann J, Hense H-W. Risikoabschätzung tödlicher Herz-Kreislauferkrankungen - Die neuen SCORE-Deutschland-Tabellen für die Primärprävention. Dtsch Arztebl 2005; 102: A 1808-1812
13. National Cholesterol Education Program. Adult Treatment Panel III. JAMA 2001; 285: 2486-2495
14. Roques F, Nashef SAM, Michel P et al. Risk factors and outcome in European cardiac surgery: analysis of the Euro-SCORE multinational database of 19030 patients. Eur J Card Thorac Surg 1999; 15: 816-823
15. Shepherd J, Cobbe SM, Ford I, Lorimer AR, McKillop JH, Ford I et al. West Of Scotland Coronary Prevention Study (WOSCOPS): Identification of high risk groups and comparison with other cardiovascular Intervention trials. Lancet 1996; 348: 1339-1342
16. Stamler J, Stamler R, Neaton JD et al. Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy: Findings for 5 Large Cohorts of Young Adult and Middle-Aged Men and Women. JAMA 1999; 282: 2012-2018
17. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350 (Pubitemid 32378388)
18. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet 2004; 364: 937-952
19. Gohlke H, Winter M, Karoff M, Held K. CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention. Eur J Cardiovasc Prev Rehabil 2007; 14: 141-148